Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saraswati Sukumar

Showing results (71-80 of 163) with videos related to

Pageof 17
Sort By:
Genes, Chromosomes & Cancer|February 4, 2012
Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancersXiang Jiao, Laura D Wood, Monica Lindman, et al.
Molecular Oncology|March 16, 2017
Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitorsVanessa F Merino, Soonweng Cho, Xiaohui Liang, et al.
Cancer Research|January 23, 2014
Genetic and phenotypic diversity in breast tumor metastasesVanessa Almendro, Hee Jung Kim, Yu-Kang Cheng, et al.
Journal of Medicinal Chemistry|March 31, 2006
Benzoylphenylurea sulfur analogues with potent antitumor activityGurulingappa Hallur, Antonio Jimeno, Susan Dalrymple, et al.
Carcinogenesis|May 3, 2019
Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical studyGuannan Wang, Chuang Chen, Priya Pai, et al.
Plos One|May 10, 2013
HMGA1: a master regulator of tumor progression in triple-negative breast cancer cellsSandeep N Shah, Leslie Cope, Weijie Poh, et al.
International Journal of Nanomedicine|June 23, 2022
In situ Injection of pH- and Temperature-Sensitive Nanomaterials Increases Chemo-Photothermal Efficacy by Alleviating the Tumor Immunosuppressive MicroenvironmentJianhua Liu, Liantao Guo, Yan Rao, et al.
Annals of Translational Medicine|May 14, 2021
Intraductal administration of N-methyl-N-nitrosourea as a novel rodent mammary tumor modelDongcheng Gao, Jianhua Liu, Jingping Yuan, et al.
Molecular & Cellular Proteomics : MCP|September 3, 2015
Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast CancerXinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, et al.
Cancer Research|July 1, 2010
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancerPang-Kuo Lo, Ji Shin Lee, Xiaohui Liang, et al.
Pageof 17

Showing results (71-80 of 163) with videos related to

Sort By:
Pageof 17
Genes, Chromosomes & Cancer|February 4, 2012
Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancersXiang Jiao, Laura D Wood, Monica Lindman, et al.
Molecular Oncology|March 16, 2017
Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitorsVanessa F Merino, Soonweng Cho, Xiaohui Liang, et al.
Cancer Research|January 23, 2014
Genetic and phenotypic diversity in breast tumor metastasesVanessa Almendro, Hee Jung Kim, Yu-Kang Cheng, et al.
Journal of Medicinal Chemistry|March 31, 2006
Benzoylphenylurea sulfur analogues with potent antitumor activityGurulingappa Hallur, Antonio Jimeno, Susan Dalrymple, et al.
Carcinogenesis|May 3, 2019
Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical studyGuannan Wang, Chuang Chen, Priya Pai, et al.
Plos One|May 10, 2013
HMGA1: a master regulator of tumor progression in triple-negative breast cancer cellsSandeep N Shah, Leslie Cope, Weijie Poh, et al.
International Journal of Nanomedicine|June 23, 2022
In situ Injection of pH- and Temperature-Sensitive Nanomaterials Increases Chemo-Photothermal Efficacy by Alleviating the Tumor Immunosuppressive MicroenvironmentJianhua Liu, Liantao Guo, Yan Rao, et al.
Annals of Translational Medicine|May 14, 2021
Intraductal administration of N-methyl-N-nitrosourea as a novel rodent mammary tumor modelDongcheng Gao, Jianhua Liu, Jingping Yuan, et al.
Molecular & Cellular Proteomics : MCP|September 3, 2015
Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast CancerXinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, et al.
Cancer Research|July 1, 2010
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancerPang-Kuo Lo, Ji Shin Lee, Xiaohui Liang, et al.
Pageof 17